Literature DB >> 11414546

Generalized anxiety disorder: nature and course.

H U Wittchen1, J Hoyer.   

Abstract

Generalized anxiety disorder (GAD) is a chronic and highly prevalent disorder in the adult population, yet it remains a relatively poorly understood condition. Clinicians may be familiar with the symptoms of enduring excessive worrying, anxiety, and hypervigilance that are characteristic of GAD, but may not necessarily recognize that these are usually symptoms of a distinct psychiatric disorder. Despite changes in diagnostic criteria, estimates of prevalence for GAD are remarkably consistent across epidemiologic studies. Lifetime prevalence in the general population is estimated at 5% (DSM-III and/or DSM-III-R criteria), with rates as high as 10% among women aged 40 years and above, and cross-sectional rates among primary care attenders are about 8%, making GAD the most prevalent anxiety disorder in primary care. The age at onset of GAD differs from that of other anxiety disorders: prevalence rates are low in adolescents and young adults but increase substantially with age. Females are at greater risk than males, and the disorder is correlated with being unemployed or a housewife or having a chronic medical illness. GAD is frequently associated with comorbid depression and other anxiety and somatoform disorders. Significant GAD-specific disability occurs even when comorbidity is not present.

Entities:  

Mesh:

Year:  2001        PMID: 11414546

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  67 in total

Review 1.  Treating generalised anxiety disorder.

Authors:  Alison Tonks
Journal:  BMJ       Date:  2003-03-29

2.  Human and economic burden of GAD, subthreshold GAD, and worry in a primary care sample.

Authors:  Sarah J Kertz; Janet Woodruff-Borden
Journal:  J Clin Psychol Med Settings       Date:  2011-09

Review 3.  MRI studies in late-life mood disorders.

Authors:  Carmen Andreescu; Howard Aizenstein
Journal:  Curr Top Behav Neurosci       Date:  2012

4.  Anxiety Sensitivity and Its Factors in Relation to Generalized Anxiety Disorder among Adolescents.

Authors:  Ashley A Knapp; Heidemarie Blumenthal; Emily R Mischel; Christal L Badour; Ellen W Leen-Feldner
Journal:  J Abnorm Child Psychol       Date:  2016-02

5.  Prevalence and features of generalized anxiety disorder in Department of Veteran Affairs primary care settings.

Authors:  Melissa E Milanak; Daniel F Gros; Kathryn M Magruder; Olga Brawman-Mintzer; B Christopher Frueh
Journal:  Psychiatry Res       Date:  2013-05-07       Impact factor: 3.222

Review 6.  Sex-dependent mental illnesses and mitochondria.

Authors:  Akiko Shimamoto; Virginie Rappeneau
Journal:  Schizophr Res       Date:  2017-03-06       Impact factor: 4.939

7.  Screening for Generalized Anxiety Disorder in inpatient psychosomatic rehabilitation: pathological worry and the impact of depressive symptoms.

Authors:  Simone Salzer; Christian Stiller; Achim Tacke-Pook; Claus Jacobi; Eric Leibing
Journal:  Psychosoc Med       Date:  2009-07-09

8.  Recognizing and managing anxiety disorders in primary health care in Turkey.

Authors:  Mehtap Kartal; Ozlem Coskun; Nesrin Dilbaz
Journal:  BMC Fam Pract       Date:  2010-04-28       Impact factor: 2.497

Review 9.  Generalised anxiety disorder: treatment options.

Authors:  John J Sramek; Victoria Zarotsky; Neal R Cutler
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  Duloxetine for the treatment of generalized anxiety disorder: a review.

Authors:  Ahsan Y Khan; Matthew Macaluso
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.